Clik here to view.
EOS imaging Obtains Marketing Approval in South Korea
PARIS EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopaedic medical imaging, today announced that the Company has received approval from the Korean Food and Drug...
View ArticleClik here to view.
BioNet Appoints New COO and Accelerates the Development of New Recombinant...
BANGKOK BioNet-Asia, a vaccine company focused on vaccine discovery and supply, announced that Georges Thiry has been appointed COO of the company, effective early 2015. “Georges Thiry’s invaluable...
View ArticleClik here to view.
PharmAbcine Announces Global Licensing Deal with Triphase Accelerator...
DAEJEON, Korea, TORONTO & SAN DIEGO PharmAbcine, a private biotechnology company focused on the discovery and development of novel bi-specific antibodies, today announced a new global licensing...
View ArticleClik here to view.
Dr. Reddy’s Q2 and H1 FY15 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited consolidated financial results for the quarter ended September 30, 2014 under International Financial...
View ArticleClik here to view.
Cerus Announces Agreement With Kawasumi Laboratories for the Development of...
CONCORD, Calif. Cerus Corporation (NASDAQ: CERS) announced today that it has entered into a partnership agreement with Kawasumi Laboratories to develop an INTERCEPT platelet kit designed for use in...
View ArticleClik here to view.
Vantage Health Forms Strategic Partnership with Theranostics Laboratory
REDWOOD CITY, Calif. Vantage Health Inc., (OTCQB:VNTH) (“Vantage Health”) or (the “Company”) today announced that it has entered into a strategic partnership with Theranostics Laboratory, a...
View ArticleClik here to view.
エリテック、フランス金融市場庁からの許可第14-566号を受けて目論見書を公表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬を開発するフランスのバイオ製薬企業のエリテック（Paris:ERYP）（Euronext Paris: FR0011471135 – ERYP）は本日、目論見書の許可を取得したと発表しました。 許可の取得...
View ArticleClik here to view.
Spinal Stenosis : Non-Surgical Treatment by Best Center in Thailand at...
BANGKOK Phyathai Nawamin International Hospital recognizes the importance of the disease, spinal stenosis, which has created pain and agony for patients. It also affects the daily life of the...
View ArticleClik here to view.
Hoya Announces Second Quarter Financial Results
TOKYO Hoya Corporation (TOKYO: 7741) today announced financial results for the second quarter ended September 30, 2014. During the quarter, revenues totaled 121,242 million yen, increasing by 18.6%...
View ArticleClik here to view.
エリテック、腫瘍分野での適応症拡大と臨床開発加速に向けた3000万ユーロの資金調達に成功
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（Euronext Paris: FR0011471135 – ERYP）は本日、総額3000万ユーロの増資を成功裏に完了したと発表しました。 エリテックのGil...
View ArticleClik here to view.
Transgenomic and University of Melbourne Collaborate to Further Validate...
OMAHA, Neb. Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and...
View ArticleClik here to view.
Akebiaが慢性腎臓病に関連した貧血を伴う非透析患者を対象にAKB-6548を検討した第2b相試験で、優れて良好な結果が得られたと発表
米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — 低酸素誘導因子（HIF）の生物学を通じて腎臓病患者に革新的治療薬を提供することに傾注するバイオ製薬企業のAkebia Therapeutics,...
View ArticleClik here to view.
亚狮康股份有限公司选用Medidata作为企业提升临床开发的技术平台
纽约 (美国商业资讯) — Medidata (NASDAQ:MDSO) 是生命科学领域全球领先的临床研究云解决方案供应商，该公司今天宣布已经与专攻肿瘤学的生物技术公司亚狮康股份有限公司签署一份企业协议。亚狮康采用业界领先的Medidata Clinical Cloud™ 来支持该公司的战略，即通过在亚洲开展优质高效的临床开发，来扩大其授权引进(in-licensed)的药物阵容的价值。...
View ArticleClik here to view.
Medidata Selected by ASLAN Pharmaceuticals as Enterprise-Wide Technology...
NEW YORK Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has signed an enterprise agreement with ASLAN...
View ArticleClik here to view.
ピーエスシー、社名を「ファインデックス」に変更
愛媛県松山市 （ビジネスワイヤ） — 株式会社ピーエスシー（JASDAQ：3649 本社：愛媛県松山市三番町4-9-6 社長：相原輝夫）は、事業強化の為、「ファインデックス（FINDEX）」に社名を変更することをお知らせいたします。 新社名 株式会社ファインデックス（英名：FINDEX Inc.） 変更日 2014年11月1日 会社情報...
View ArticleClik here to view.
Cerus Announces Agreement With Kawasumi Laboratories for the Development of...
CONCORD, Calif. Cerus Corporation (NASDAQ: CERS) announced today that it has entered into a partnership agreement with Kawasumi Laboratories to develop an INTERCEPT platelet kit designed for use in...
View ArticleClik here to view.
ImpediMed Announced Medicare Payment for New L-Dex® Category I Code
BRISBANE, Australia & SAN DIEGO ImpediMed (ASX:IPD) is pleased to announce today the Centers for Medicare and Medicaid Services (CMS) has published the valuation for CPT® Category I Code 93702...
View ArticleClik here to view.
ex scientiaが精神疾患向け新規医薬品の研究でサノビオン・ファーマシューティカルズと提携
英ダンディー （ビジネスワイヤ） — polypharmacologyを駆使する創薬企業のex scientia Ltd.は本日、精神疾患向け新規医薬品の創薬と最適化で協業すべく、サノビオン・ファーマシューティカルズと契約を締結したと発表しました。 480万米ドル規模の新たな戦略的提携の一部として、ex...
View ArticleClik here to view.
ex scientia Ltd. Partners with Sunovion Pharmaceuticals Inc. to Research New...
DUNDEE, United Kingdom ex scientia Ltd., the polypharmacology driven drug discovery company, announced today that they have signed an agreement with Sunovion Pharmaceuticals Inc., to collaborate on...
View ArticleClik here to view.
Taiyo Pacific Partners Becomes Major Shareholder in Peptidream, Inc. with...
TOKYO Taiyo Pacific Partners announced today that it has accumulated in excess of 5% in Peptidream, Inc. (4587) to become Peptidream’s second largest institutional shareholder. Peptidream aspires to...
View Article